Webinar: Managing the Risk of Open Payments – Validate Spend Report Before CMS Submission

With the next filing period for spend data under the Sunshine Act coming up quickly, Ned Mumtaz and Brian Dahl are hosting a webinar on how to help you manage the risk of open payments and open payments reporting. The webinar will take place on Thursday, January 21, 2016, at 2:00 pm EST. The webinar will explain how you can work to protect yourself from risks of audits or fines, even before you submit your final report to the Centers for Medicare and Medicaid Services (CMS).

Mumtaz and Dahl will discuss a range of important topics, including some of the potential implications of public availability of this data and how governmental authorities may use the Sunshine Act data to generate enforcement actions.

If you attend the webinar, you will learn how to run an independent audit on your spend before building state and federal reports, spot an outlier before submitting your final report, and improve your compliance program using data analytics.

Brian Dahl is the principal of Dahl Compliance Consulting, LLC, and is the architect of the Corporate Compliance Programs at both Teva Pharmaceuticals and Takeda Pharmaceuticals. Ned Mumtaz is leading Streebo’s transparency directive program in the United States and European Union; he has over twenty years of experience in the pharmaceutical industry and has led several Sunshine implementation programs in the United States.

The webinar is moderated by Thomas Sullivan, the Chief Editor of Policy and Medicine. Policy and Medicine has been the number one information source for the Physician Payment Sunshine Act for the past five years, according to Google.

If you are interesting in attending, you can register here.